Akeso, Inc. (9926) Price & Analysis

Compare

30 Followers

9926 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$50.50 - HK$179.00

Previous CloseN/A

Volume3.49M

Average Volume (3M)12.39M

Market Cap

HK$135.59B

Enterprise ValueHK$79.38B

Total Cash (Recent Filing)HK$7.32B

Total Debt (Recent Filing)HK$3.95B

Price to Earnings (P/E)―

Beta0.69

Next Earnings

Apr 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.70

Shares Outstanding921,143,200

10 Day Avg. Volume15,969,650

30 Day Avg. Volume12,385,950

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$157.68

Price Target Upside1.93% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

Bulls Say, Bears Say

Bulls Say

Financial PerformanceAkeso demonstrated improved cost efficiency with selling and R&D expenses as a percentage of product sales shrinking.

Global DevelopmentAkeso is accelerating the global development of AK104, including starting a global Phase 2 registrational trial for an important indication.

Sales GrowthThe NRDL inclusions for Akeso's products, such as AK104 and AK112, have significantly contributed to sales growth.

Bears Say

Market CompetitionDespite positive results, intense market competition may pose a challenge for Akeso's market share growth.

Regulatory RiskPotential regulatory hurdles in global markets might impact the speed of Akeso's product approvals outside China.

Akeso, Inc. News

Akeso, Inc. Completes Share Placement, Raises HK$3.49 Billion for R&D

Akeso, Inc. ( ($HK:9926) ) has provided an update. Akeso, Inc. has successfully completed the placing of new...

3d ago

9926

Akeso, Inc.: Strong Sales Performance and Strategic Advancements Drive Buy Rating

Akeso, Inc., the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jill Wu from...

10d ago

Akeso, Inc. Announces Share Placement to Boost Market Position

Akeso, Inc. ( ($HK:9926) ) just unveiled an update. Akeso, Inc. has announced the placement of new and...

10d ago

9926

Akeso, Inc. Reports Revenue Growth but Faces Increased Losses in H1 2025

Akeso, Inc. ( ($HK:9926) ) just unveiled an update. Akeso, Inc. reported a 37.75% increase in revenue for...

12d ago

9926

Akeso, Inc. Details Nomination Committee’s Terms of Reference

The latest announcement is out from Akeso, Inc. ( ($HK:9926) ). Akeso, Inc. has outlined the terms of...

12d ago

9926

Akeso, Inc. Schedules Board Meeting for Interim Results Approval

An announcement from Akeso, Inc. ( ($HK:9926) ) is now available. Akeso, Inc. has announced that its board...

24d ago

9926

Akeso, Inc. Announces Successful Passing of AGM and EGM Resolutions

Akeso, Inc. ( ($HK:9926) ) has provided an announcement. Akeso, Inc. announced the successful passing of all resolutions...

2M ago

9926

Akeso, Inc. Announces Extraordinary General Meeting for Key Resolutions

Akeso, Inc. ( ($HK:9926) ) just unveiled an update. Akeso, Inc. has announced an extraordinary general meeting to...

3M ago

9926

Akeso, Inc. Announces Annual General Meeting with Key Resolutions

An update from Akeso, Inc. ( ($HK:9926) ) is now available. Akeso, Inc. has announced its upcoming annual...

3M ago

9926

Akeso’s Cadonilimab Gains Approval for First-Line Cervical Cancer Treatment

Akeso, Inc. ( ($HK:9926) ) has issued an announcement. Akeso, Inc. announced that China’s National Medical Products Administration...

3M ago

9926

9926 FAQ

What was Akeso, Inc.’s price range in the past 12 months?

Akeso, Inc. lowest stock price was HK$50.50 and its highest was HK$179.00 in the past 12 months.

What is Akeso, Inc.’s market cap?

Akeso, Inc.’s market cap is HK$135.59B.

When is Akeso, Inc.’s upcoming earnings report date?

Akeso, Inc.’s upcoming earnings report date is Apr 01, 2026 which is in 206 days.

How were Akeso, Inc.’s earnings last quarter?

Akeso, Inc. released its earnings results on Aug 26, 2025. The company reported -HK$0.7 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.7.

Is Akeso, Inc. overvalued?

According to Wall Street analysts Akeso, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Akeso, Inc. pay dividends?

Akeso, Inc. does not currently pay dividends.

What is Akeso, Inc.’s EPS estimate?

Akeso, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Akeso, Inc. have?

Akeso, Inc. has 921,143,200 shares outstanding.

What happened to Akeso, Inc.’s price movement after its last earnings report?

Akeso, Inc. reported an EPS of -HK$0.7 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.295%.

Which hedge fund is a major shareholder of Akeso, Inc.?

Currently, no hedge funds are holding shares in HK:9926

Akeso, Inc. Stock Smart Score

Outperform

Fundamentals

Return on Equity

-14.40%

Trailing 12-Months

Asset Growth

29.53%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Akeso, Inc.

Akeso, Inc. (9926) is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative antibody drugs for the treatment of cancer, autoimmune diseases, and other serious health conditions. Operating primarily in the biotechnology and pharmaceuticals sectors, Akeso focuses on leveraging its proprietary technology platform to create a diverse pipeline of monoclonal and bispecific antibodies that address unmet medical needs.

Akeso, Inc. (9926) Earnings & Revenues

Historic Earnings Reports

9926 Stock 12 Month Forecast

Average Price Target

HK$157.68

▲(1.93% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"49":"HK$49","89":"HK$89","129":"HK$129","169":"HK$169","209":"HK$209"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":208,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$208.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":157.68,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$157.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$65.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[49,89,129,169,209],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158,161.84615384615384,165.69230769230768,169.53846153846155,173.3846153846154,177.23076923076923,181.07692307692307,184.92307692307693,188.76923076923077,192.6153846153846,196.46153846153845,200.30769230769232,204.15384615384616,{"y":208,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158,157.97538461538463,157.95076923076923,157.92615384615385,157.90153846153845,157.87692307692308,157.8523076923077,157.8276923076923,157.80307692307693,157.77846153846156,157.75384615384615,157.72923076923078,157.70461538461538,{"y":157.68,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158,150.84615384615384,143.69230769230768,136.53846153846155,129.3846153846154,122.23076923076923,115.07692307692307,107.92307692307692,100.76923076923077,93.61538461538461,86.46153846153845,79.3076923076923,72.15384615384615,{"y":65,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":50.3,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.6,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.2,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.65,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.95,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >